In patients with prostate cancer, Lp‐PLA2 has been shown to promote cancer cell migration and invasion, possibly through generation of oxidized nonesterified fatty acids and lysophosphatidylcholine (LPC) (38). The gene discussed is PLA2G7; the disease is prostate carcinoma.